Search

Your search keyword '"Sigurdsson, Vigfús"' showing total 174 results

Search Constraints

Start Over You searched for: Author "Sigurdsson, Vigfús" Remove constraint Author: "Sigurdsson, Vigfús"
174 results on '"Sigurdsson, Vigfús"'

Search Results

5. Do summative entrustment decisions actually lead to entrustment?

8. Development and validation of risk calculators for people with 'thin' melanomas on their skin to predict the likelihood that their cancer will return: a plain language summary of publication

9. Do summative entrustment decisions actually lead to entrustment?

11. Development and validation of risk calculators for people with “thin” melanomas on their skin to predict the likelihood that their cancer will return: a plain language summary of publication

17. Time interval between diagnostic excision-biopsy of a primary melanoma and sentinel node biopsy: effects on the sentinel node positivity rate and survival outcomes

18. Effect of the time interval between melanoma diagnosis and sentinel node biopsy on the size of metastatic tumour deposits in node-positive patients

19. The progressive relationship between increasing Breslow thickness and decreasing survival is lost in patients with ultra-thick melanomas (≥15mm in thickness)

20. Time interval between diagnostic excision-biopsy of a primary melanoma and sentinel node biopsy: effects on the sentinel node positivity rate and survival outcomes

21. Effect of the time interval between melanoma diagnosis and sentinel node biopsy on the size of metastatic tumour deposits in node-positive patients

27. Diagnostisches Next Generation Sequencing bei neonataler Erythrodermie

28. Diagnostic next generation sequencing in neonatal erythroderma

29. Development and Validation of Nomograms to Predict Local, Regional, and Distant Recurrence in Patients With Thin (T1) Melanomas

30. High discordance rate in assessing sentinel node positivity in cutaneous melanoma: Expert review may reduce unjustified adjuvant treatment

31. Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous Melanoma

32. Diagnostic next generation sequencing in neonatal erythroderma

34. Development and Validation of Nomograms to Predict Local, Regional, and Distant Recurrence in Patients With Thin (T1) Melanomas

40. Subtyping Cutaneous Melanoma Matters

41. Quantifying the additional prognostic value of sentinel lymph node status over established clinicopathologic primary tumor features for predicting survival outcomes in melanoma patients.

44. Desmoplastic melanoma: The role of pure and mixed subtype in sentinel lymph node biopsy and survival

45. Subtyping Cutaneous Melanoma Matters

Catalog

Books, media, physical & digital resources